Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Molecular classification of unknown primary cancer.

Bender RA, Erlander MG.

Semin Oncol. 2009 Feb;36(1):38-43. doi: 10.1053/j.seminoncol.2008.10.002. Review.

PMID:
19179186
2.

Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.

Horlings HM, van Laar RK, Kerst JM, Helgason HH, Wesseling J, van der Hoeven JJ, Warmoes MO, Floore A, Witteveen A, Lahti-Domenici J, Glas AM, Van't Veer LJ, de Jong D.

J Clin Oncol. 2008 Sep 20;26(27):4435-41. doi: 10.1200/JCO.2007.14.6969.

PMID:
18802156
3.

Diagnosis of metastatic neoplasms: molecular approaches for identification of tissue of origin.

Monzon FA, Koen TJ.

Arch Pathol Lab Med. 2010 Feb;134(2):216-24. doi: 10.1043/1543-2165-134.2.216. Review.

PMID:
20121609
4.

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.

Tothill RW, Kowalczyk A, Rischin D, Bousioutas A, Haviv I, van Laar RK, Waring PM, Zalcberg J, Ward R, Biankin AV, Sutherland RL, Henshall SM, Fong K, Pollack JR, Bowtell DD, Holloway AJ.

Cancer Res. 2005 May 15;65(10):4031-40. Erratum in: Cancer Res. 2005 Sep 1;65(17):8057.

5.

[Molecular diagnostic methods designed for clinical approach to cancer of unknown origin].

Fujita Y, Nishio K.

Gan To Kagaku Ryoho. 2009 Jun;36(6):923-6. Review. Japanese.

PMID:
19542713
6.

Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue.

Koh SS, Opel ML, Wei JP, Yau K, Shah R, Gorre ME, Whitman E, Shitabata PK, Tao Y, Cochran AJ, Abrishami P, Binder SW.

Mod Pathol. 2009 Apr;22(4):538-46. doi: 10.1038/modpathol.2009.8. Epub 2009 Mar 6.

7.

Switching benchmarks in cancer of unknown primary: from autopsy to microarray.

Pentheroudakis G, Golfinopoulos V, Pavlidis N.

Eur J Cancer. 2007 Sep;43(14):2026-36. Epub 2007 Aug 14.

PMID:
17698346
8.

Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.

Monzon FA, Medeiros F, Lyons-Weiler M, Henner WD.

Diagn Pathol. 2010 Jan 13;5:3. doi: 10.1186/1746-1596-5-3.

9.

Gene expression profiles help identify the tissue of origin for metastatic brain cancers.

Wu AH, Drees JC, Wang H, VandenBerg SR, Lal A, Henner WD, Pillai R.

Diagn Pathol. 2010 Apr 26;5:26. doi: 10.1186/1746-1596-5-26.

10.

[Comparative genomic classification of human hepatocellular carcinoma].

Kaposi-Novák P.

Magy Onkol. 2009 Mar;53(1):61-7. doi: 10.1556/MOnkol.53.2009.1.9. Hungarian.

11.

New strategies for carcinoma of unknown primary: the role of tissue-of-origin molecular profiling.

Varadhachary G.

Clin Cancer Res. 2013 Aug 1;19(15):4027-33. doi: 10.1158/1078-0432.CCR-12-3030. Epub 2013 Mar 21.

12.

Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary.

Bridgewater J, van Laar R, Floore A, Van'T Veer L.

Br J Cancer. 2008 Apr 22;98(8):1425-30. doi: 10.1038/sj.bjc.6604315. Epub 2008 Apr 15.

13.

Molecular classification of cancers of unknown primary site.

Greco FA, Erlander MG.

Mol Diagn Ther. 2009 Dec 1;13(6):367-73. doi: 10.2165/11530360-000000000-00000. Review.

PMID:
19925034
14.

Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.

Varadhachary GR, Talantov D, Raber MN, Meng C, Hess KR, Jatkoe T, Lenzi R, Spigel DR, Wang Y, Greco FA, Abbruzzese JL, Hainsworth JD.

J Clin Oncol. 2008 Sep 20;26(27):4442-8. doi: 10.1200/JCO.2007.14.4378.

PMID:
18802157
15.

Gene expression profiling in cancers of unknown primary.

Varadhachary GR, Raber MN.

J Clin Oncol. 2009 Sep 1;27(25):e85-6; author reply e87-8. doi: 10.1200/JCO.2009.23.7644. Epub 2009 Jul 27. No abstract available.

PMID:
19635993
16.

Prognostic gene signatures for non-small-cell lung cancer.

Boutros PC, Lau SK, Pintilie M, Liu N, Shepherd FA, Der SD, Tsao MS, Penn LZ, Jurisica I.

Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2824-8. doi: 10.1073/pnas.0809444106. Epub 2009 Feb 5.

17.

Cancer of unknown primary site: missing primary or missing biology?

Pentheroudakis G, Briasoulis E, Pavlidis N.

Oncologist. 2007 Apr;12(4):418-25. Review.

18.

[Cancer of unknown primary site origin--advances in diagnosis and therapy].

Plot L, Dovrish Z, Hadari R, Weisenberg N, Zehavi T, Nisenbaum B, Amital H.

Harefuah. 2008 Apr;147(4):294-8, 376, 375. Hebrew.

PMID:
18686808
19.

Multicenter validation of a 1,550-gene expression profile for identification of tumor tissue of origin.

Monzon FA, Lyons-Weiler M, Buturovic LJ, Rigl CT, Henner WD, Sciulli C, Dumur CI, Medeiros F, Anderson GG.

J Clin Oncol. 2009 May 20;27(15):2503-8. doi: 10.1200/JCO.2008.17.9762. Epub 2009 Mar 30.

PMID:
19332734
20.

Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development.

Smith IM, Mithani SK, Liu C, Chang SS, Begum S, Dhara M, Westra W, Sidranksy D, Califano JA.

Arch Otolaryngol Head Neck Surg. 2009 May;135(5):487-95. doi: 10.1001/archoto.2009.43.

PMID:
19451471

Supplemental Content

Support Center